20Jan 2017

RARE CAUSE AND PRESENTATION OF SEVERE HYPERTRIGLYCERIDEMIA.

  • Department of Emergency Medicine, King Fahad Hospital of the University, Imam Abdulrahman Alfaisal university, Alkhobar, Saudi Arabia.
Crossref Cited-by Linking logo
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author
  1. Berglund L, Brunzell JD, Goldberg AC, Goldberg IJ, Sacks F, Murad MH, et al, Endocrine society. Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline.\
  2. Kroll MH, Elin RJ. Interference with clinical laboratory analyses. ClinChem 1994;40:1996–2005.
  3. Sandhya, V., Balasubramanian, A., Rajasekar, D., Kothai, G. and Sundari, S.M., Pink Blood. TC, 600, p.168.
  4. Paudel, Y.P., Kasyap, A.K., Shrestha, A. and Baral, R., 2010. High lipemic serum: a case report. Nepal Med Coll J, 12(1), pp.61-62
  5. Pillai, A.S., 2009. White, opaque fluid in a blood draw. Hypertriglyceridemia. American family physician, 79(8), p.699.
  6. Yuan G, Al-Shali KZ, Hegele RA. Hypertriglyceridemia: its etiology, effects, and treatment. CMJA 2007;176:1113–1120.
  7. Brunzell JD. Clinical practice. Hypertriglyceridemia. NEJM 2007;357:1009–1017.
  8. Crouse 3rd JR. Hypertriglyceridemia: a contraindication to the use of bile acid binding resins. The American Journal of Medicine 1987;83:243–248.
  9. Vu-Dac N, Gervois P, Torra IP, et al. Retinoids increase human apo c-iii expression at the transcriptional level via the retinoid x receptor. Contribution to the hypertriglyceridemic action of retinoids. The Journal of Clinical Investigation 1998;102:625–632.
  10. Stone NJ. Secondary causes of hyperlipidemia. The Medical Clinics of North America 1994;78:117–141.
  11. Carr MC, Brunzell JD. Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk. The Journal of Clinical Endocrinology and Metabolism 2004;89:2601–2607.
  12. Luo L, Pu X, Wang Y, et al. Impaired plasma lipid profiles in acute hepatitis. Lipids in Health and Disease 2010;9:5.
  13. Kronenberg F. Dyslipidemia and nephrotic syndrome: recent advances. Journal of Renal Nutrition: The Official Journal of the Council on Renal Nutrition of the National Kidney Foundation 2005;15:195–203.
  14. Lindkvist B, Appelros S, Regnér S, Manjer J. A prospective cohort study on risk of acute pancreatitis related to serum triglycerides, cholesterol and fasting glucose. Pancreatology 2012;12:317.
  15. Ryder KW, Glick MR. Erroneous laboratory results from hemolyzed, icteric, and lipemic specimens. ClinChem 1993;39:175–176.
  16. Mensink RP, Zock PL, Kester AD, et al. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to hdl cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. The American Journal of Clinical Nutrition 2003;77:1146–1155.
  17. Capell WH, Eckel RH. Severe hypertriglyceridemia with a historyof treatment failure. Nature ClinPractEndocrinolMetab 2005;1:53–58.
  18. Rosen IM, Sams RW 2nd. Common questions in managing hyperlipidemia. Prim Care Clin Office Pract 2006;33:903–921.
  19. Abourbih S, Filion KB, Joseph L, et al. Effect of fibrates on lipid profiles and cardiovascular outcomes: a systematic review. The American Journal of Medicine 2009;122:e961–e968.
  20. Rubins HB, Robins SJ, Collins D, et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans affairs high-density lipoprotein cholesterol intervention trial study group. The New England Journal of Medicine 1999;341:410–418.
  21. Pasternak RC, Smith SC, Bairey-Merz CN, et al. ACC/AHA/NHLBI clinical advisory on the use and safety of statin. J Am CollCardiol 2002;40:567–572.
  22. Graham DJ, Staffa JA, Shatin D, et al. Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs. JAMA 2004;292:2585–2590.
  23. Berger Z, Quera R, Poniachik J, et al. Heparin and/or insulin treatment of acute pancreatitis caused by hypertriglyceridemia. Rev Med Chil 2001;129:1373–1378.
  24. Furuya T, Komatsu M, Takahashi K, et al. Plasma exchange for hypertriglyceridemic acute necrotizing pancreatitis: report of two cases. TherApher 2002;6:454–458.
  25. Ewald N, Kloer HU. Severe hypertriglyceridemia: an indication for apheresis? AtherosclerSuppl 2009;10:49–52.
  26. Bramlage CP, Schröder K, Bramlage P, et al. Predictors of complications in therapeutic plasma exchange. J ClinApher 2009;24:225–231.

[Adnan Al Awami, Sukayna Al-Faraj and Amal Al Sulaibikh. (2017); RARE CAUSE AND PRESENTATION OF SEVERE HYPERTRIGLYCERIDEMIA. Int. J. of Adv. Res. 5 (Jan). 632-638] (ISSN 2320-5407). www.journalijar.com

Adnan Talib Alawami
Department of Emergency Medicine, King Fahad Hospital of the University, Imam Abdulrahman Alfaisal university, Alkhobar, Saudi Arabia

DOI:

Article DOI: 10.21474/IJAR01/2791      
DOI URL: http://dx.doi.org/10.21474/IJAR01/2791

Download Full Paper

Download PDF No. of Downloads: 14 | No. of Views: 96